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To investigate the molecular mechanisms involved in paramyxovirus-induced cell fusion, the function and structure of
synthetic peptide analogs of the sequence from the leucine zipper region (heptad repeat region 2) of the Newcastle disease
virus fusion protein (F) were characterized. As previously reported (Young et al., Virology, 238, 291), a peptide with the
sequence ALDKLEESNSKLDKVNVKLT (amino acids 478–497 of the F protein) inhibited syncytia formation after transfection
of Cos cells with the hemagglutinin–neuraminidase and F protein cDNAs. A peptide analog which had an alanine residue in
place of the first leucine residue in the zipper motif (ALDKAEESNSKLDKVNVKLT) retained inhibitory activity but less than the
original peptide. Further loss in activity was observed in a peptide in which two of the leucine residues were replaced with
alanine (ALDKAEESNSKADKVNVKLT), and a peptide which had all leucine residues in the zipper motif replaced with alanine
(ALDKAEESNSKADKVNVKAT) had no inhibitory activity. The three-dimensional conformations of these peptides in aqueous
solution were determined through the use of nuclear magnetic spectroscopy and molecular modeling. Results showed that
while the wild-type peptide formed a helix with properties between an a-helix and a 310 helix with leucine residues aligned
along one face of the helix, progressive substitution of leucine residues with alanine resulted in the progressive loss of helical
structure. The results suggest that alterations of leucine residues in the zipper motif disrupt secondary structure of the
peptide and that this structure is critical to the inhibitory activity of the peptide. © 1998 Academic Press
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INTRODUCTION
All enveloped virions contain one or more glycopro-
teins which direct membrane fusion required for virus
entry. Many of these proteins have common recogniz-
able sequence motifs (Hernandez et al., 1996) including
a polar or hydrophobic sequence, termed the fusion
peptide (Hernandez et al., 1996; White, 1990, 1992), as
well as one or more heptad repeat (HR) regions (Buck-
land and Wild, 1989; Chambers et al., 1990; deGroot et
al., 1987; Wild et al., 1994) which, in some cases, are
leucine zippers (Buckland and Wild, 1989; Wild et al.,
1994). While several different lines of experiments have
suggested that HR regions of fusion proteins are quite
important in the fusion reaction, their precise role in
fusion is not yet clear.
Membrane fusion directed by paramyxoviruses such
as Newcastle disease virus (NDV) requires two viral
glycoproteins, the fusion (F) protein and the hemagglu-
tinin–neuraminidase (HN) protein (reviewed in Lamb,
1993). While the role of the HN protein in fusion is not yet
understood, the F protein is thought to be directly re-
sponsible for the fusion reaction (Lamb, 1993). The F
protein is synthesized as a precursor F0 which must be
proteolytically cleaved to F1 and F2 to direct membrane
fusion (Lamb, 1993; Scheid and Choppin, 1974, 1978). The
fusion peptide of this protein is located at the new amino
terminus of the F1 protein generated by the cleavage of
F0. The F protein also has two heptad repeat regions in
the ectodomain of the F1 polypeptide, HR1 and HR2
(Chambers et al., 1990; Lamb, 1993). HR1 is located just
to the carboxy-terminal side of the fusion peptide, while
HR2 is adjacent to the transmembrane domain. The HR2
domain is a leucine zipper which extends for five turns of
a predicted helix. Mutational analyses of this region of
the F protein of the NDV F protein (Reitter et al., 1995) as
well as the measles virus F protein (Buckland et al., 1992)
have shown that substitution of at least two leucine
residues with alanine eliminated fusion activity without
affecting intracellular transport, surface expression, or
oligomerization of the protein.
Synthetic peptides with the sequences of the leucine
zipper region of the HIV (human immunodeficiency virus)
gp41 (Wild et al., 1994, 1992) and the F protein of several
paramyxoviruses (Lambert et al., 1996; Rapaport et al.,
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1995; Wild and Buckland, 1997; Yao and Compans, 1996)
can inhibit fusion of the homologous virus. Indeed, we
have found that a 20-amino-acid synthetic peptide with
the sequence from the carboxy-terminal region of the
NDV leucine zipper region can inhibit fusion directed by
the NDV glycoproteins (Young et al., 1997). Using nuclear
magnetic resonance spectroscopy (NMR) and molecular
modeling, we have previously reported that this peptide,
in aqueous solution, formed a helix with properties be-
tween an a helix and a 310 helix and that the leucine
residues aligned along one face of the helix (Young et al.,
1997). Because replacement of these leucine residues
with alanine in the intact protein eliminated fusion activ-
ity of the protein (Reitter et al., 1995), we were interested
in the properties of synthetic peptides with one or more
of the leucine residues replaced with alanines. We show
here that these leucine zipper peptide analogs progres-
sively lost their ability to inhibit fusion as leucine resi-
dues were replaced with alanine. Furthermore, this loss
of activity correlated with a progressive loss in structure
of the peptide in solution.
RESULTS
Synthetic peptide sequences
The HR2 region of the NDV F1 protein is located just to
the amino-terminal side of the transmembrane domain
(Fig. 1A) (Reitter et al., 1995). Beginning at aa 467 and
extending to aa 502, there are five leucine or isoleucine
residues (indicated by arrows) every seven residues (Fig.
1B). The synthetic peptide with the sequence of the
wild-type F protein from amino acid 478 to 498, NDVFz20,
previously reported to inhibit fusion directed by the NDV
F and HN proteins, is shown in Fig. 1C (Young et al.,
1997). We have previously reported that mutation of any
two of the three most carboxy-terminal leucine residues
shown in Fig. 1B eliminated the fusion activity of the F
protein (Reitter et al., 1995). A series of synthetic pep-
tides, shown in Fig. 1D, in which leucine residues were
replaced with alanine residues were characterized.
NDVFz20-L5A replaced the leucine corresponding to the
third leucine in the zipper motif with alanine. NDVFx20-
L5,12A replaced the leucines corresponding to the third
and fourth leucines in the zipper with alanine. NDVFz20-
L5,12,19A replaced leucines corresponding to the third,
fourth, and fifth leucines in the zipper motif with alanine.
Peptide inhibition of fusion mediated by F and HN
proteins
To determine the ability of these peptides to inhibit
fusion, Cos cells were transfected with HN and F cDNAs.
Transfected cells were incubated in the presence of
various concentrations of the peptides, and fusion was
measured by the size of syncytia after 48 h. As we have
previously reported (Young et al., 1997), NDVFz20 inhib-
ited cell–cell fusion, and the concentration required for
50% inhibition was approximately 2 mM (Fig. 2). Peptide
NDVFz20-L5A also inhibited fusion but less well than the
wild-type peptide, and peptide NDVFz20-L5,12A showed
FIG. 1. Location of the sequence of peptide NDVFz20 and its analogs. (A) Diagram of the fusion protein of NDV with the approximate location in
the linear sequence of structurally significant domains: HR1, heptad repeat 1; HR2, heptad repeat 2, which contains a zipper motif. (B) The sequence
of the HR2 region of the F protein of NDV with the zipper (residues 467 to 502). Arrows indicate the residues forming the zipper motif. (C) Amino acid
sequence of the NDVFz20 peptide. Numbers indicate the amino acid position within the peptide. (D) Amino acid sequences of the peptide analogs.
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even less inhibitory activity. Even at the highest concen-
trations tested (100 mM), the peptides with single and
double leucine replacements could not completely in-
hibit fusion (not shown). Peptide NDVFz20-L5,12,19A had
virtually no inhibitory activity.
NMR assignments
Assignments of the 1H spectra of the peptides in
aqueous solution were accomplished using the tech-
nique of sequence-specific resonance assignments de-
veloped by Wu¨thrich (1986). The assignments were made
by the interactive interpretation of the 2D TOCSY (Eich et
al., 1982; Hicks and Young, 1994) and ROESY (States et
al., 1982) spectra at 25°C. Interpretation of the NMR
spectra of these peptides was very similar to that of the
NDVFz20 peptide previously published (Young et al.,
1997), and therefore, the specifics of assignments are
not discussed. The aqueous solution chemical shifts for
NDVFz20-L5A, NDVFz20-L5,12A, and NDVFz20-L5,12,19A
are given in Table 1 and compared to those of the
NDVFz20 peptide. There is a three-amino-acid repeat,
L2D3K4 and L12D13K14, in the sequence of NDVFz20. In
NDVFz20-L5A, the L5, just after the first repeat, was
changed to an A which showed NOEs back to K4, con-
firming the assignments previously made for NDVFz20
(Young et al., 1997). In NDVFz20-L5,12,19A, the second
repeat was changed to A12D13K14 and also showed ob-
vious changes in the NOE cross peaks. These dramatic
changes in the NMR spectra allowed for the confirma-
tion of the original chemical shift assignments of the
NDVFz20 peptide.
Amide chemical shift temperature dependence
(ACSTD)
Amide 1Hs are directly affected by changes in temper-
ature which cause a change in the amide’s chemical
shift. Low values of the temperature dependence are
consistent with intramolecular hydrogen bonding (Rose
et al., 1985). The ACSTD for each peptide are given in
Table 1, as well as those previously obtained for the
NDVFz20 peptide. As previously reported, the NDVFz20
peptide contained five intramolecular hydrogen bonds
(low values of ACSTD) which involved the amide 1Hs of
K11, L12, D13, V15, and T20. The replacement of successive
leucines by alanine resulted in the successive loss of
intermolecular hydrogen bond formation in these pep-
tides. Two hydrogen bonds were lost in NDVFz20-L5A
which involved K11 and V15, only one hydrogen bond
remained in NDVFz20-L5,12A involving T20, while all hy-
drogen bond formation was lost in NDVFz20-L5,12,19A.
ROE connectivity
Wu¨thrich and co-workers have reported that the ob-
servation of a grouping of specific medium-range ROEs
can be used to determine the existence of secondary
structural features such as an a-helix or a b-turn (Wu¨th-
rich et al., 1984). The ROEs obtained from the ROESY
spectrum for each peptide are shown in Fig. 3, and data
for NDVFz20 are also shown for comparison. The previ-
ously obtained ROEs for the NDVFz20 peptide suggested
the presence of a helical structure that was confirmed by
molecular modeling (Young et al., 1997). As can be seen
there is a stepwise reduction in the amount of structural
information obtained for these peptides compared to that
for the NDVFz20 peptide. However, the ROEs obtained
for NDVFz20-L5A suggest that a significant portion of the
peptide is still structurally stable. The ROEs for NDVFz20-
L5,12A suggest that only the C-terminal portion of the
peptide may be stable, while the NDVFz20-L5,12,19A pep-
tide has no significant structural stability. The dab(i,i 1 3)
ROEs obtained for NDVFz20-L5A and NDVFz20-L5,12A do
suggest that each peptide does have some helical char-
acteristics.
FIG. 2. Inhibition of fusion by peptide analogs. Cos cells were
cotransfected with HN and F cDNAs (derived from the virulent strain AV
of NDV and, therefore, resulting in a protein that is cleaved intracellu-
larly (Glickman et al., 1988; Toyoda et al., 1987)) as described under
Materials and Methods. Transfected cells were incubated with 0 to 50
mM peptides added with complete medium after transfection. Medium
with peptide was replaced every 12 h. Sizes of syncytia were deter-
mined at 48 h after transfection as previously described (Sergel et al.,
1993). Values obtained are shown as a percentage of those obtained
without peptide. Each point is the average of two or three determina-
tions. Bars show extent of variation.
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TABLE 1
1H Chemical Shift (ppm) Assignments and Amide Chemical Shift Temperature Dependence (ACSTD) of 1.6 mM NDVFz20 (Young et al., 1997),
NDVFz20-L5A, NDVFz20-L5,12A, and NDVFz20-L5,12,19A (Fz20; 5, 5,12; and 5,12,19; respectively) at pH 4.0 in Aqueous Solution
Residue Peptide HN a b g d e ACSTD
A1 Fz20 — 4.09 1.50 —
5 — 4.09 1.54 —
5, 12 — 4.09 1.53 —
5, 12, 19 — 4.05 1.35
L2 Fz20 8.55 4.36 1.61 1.61 0.88, 0.92 26.9
5 8.58 4.37 1.62 1.62 0.88 27.4
5, 12 8.56 4.37 1.62 1.62 0.91 26.0
5, 12, 19 8.53 4.31 1.54 1.54 0.85 26.0
D3 Fz20 8.44 4.62 2.74, 2.80 28.2
5 8.46 4.62 2.71, 2.78 26.6
5, 12 8.46 4.62 2.71, 2.77 27.0
5, 12, 19 8.41 4.55 2.62, 2.69 27.0
K4 Fz20 8.28 4.26 1.77, 1.85 1.43 1.68 2.99 7.51 eNH3 28.9
5 8.31 4.26 1.76, 1.85 1.43 1.69 3.00 7.51 25.3
5, 12 8.30 4.26 1.76, 1.85 1.43 1.69 3.00 7.53 27.5
5, 12, 19 8.24 4.21 1.78, 1.69 1.37 1.62 3.00 7.49 27.5
L5 Fz20 8.21 4.31 1.68 1.61 0.88, 0.93 27.5
A5 5 8.34 4.28 1.40 27.0
A5 5, 12 8.33 4.28 1.40 26.5
A5 5, 12, 19 8.30 4.21 1.33 26.5
E6 Fz20 8.25 4.33 2.00, 2.11 2.43 25.0
5 8.26 4.31 1.99, 2.11 2.41 25.0
5, 12 8.26 4.31 1.99, 2.12 2.41 25.5
5, 12, 19 8.23 4.35 1.92, 2.04 2.35 25.5
E7 Fz20 8.31 4.35 2.01, 2.13 2.44 26.5
5 8.32 4.32 2.01, 2.12 2.40 26.0
5, 12 8.32 4.34 2.01, 2.11 2.40 26.0
5, 12, 19 8.28 4.36 1.93, 2.05 2.35 26.0
S8 Fz20 8.32 4.42 3.87, 3.91 26.2
5 8.33 4.43 3.86, 3.92 26.0
5, 12 8.34 4.43 3.88, 3.89 27.0
5, 12, 19 8.29 4.40 3.82 27.0
N9 Fz20 8.41 4.74 2.80, 2.88 6.88, 7.60 NH2 25.3
5 8.44 4.76 2.82, 2.88 6.92, 7.62 25.4
5, 12 8.44 4.77 2.81, 2.88 6.91, 7.62 26.5
5, 12, 19 8.39 4.71 2.75, 2.82 6.85, 7.57 26.5
S10 Fz20 8.24 4.40 3.87, 3.92 25.3
5 8.27 4.40 3.87, 3.94 26.0
5, 12 8.26 4.42 3.88, 3.92 25.5
5, 12, 19 8.21 4.40 3.83 26.0
K11 Fz20 8.26 4.30 1.88, 1.78 1.45 1.68 2.99 7.51 eNH3 22.9
5 8.28 4.32 1.78, 1.88 1.44 1.69 3.00 7.54 25.0
5, 12 8.28 4.43 1.77, 1.88 1.41, 1.45 1.69 2.99 7.53 25.0
5, 12, 19 8.23 4.25 1.81 1.38 1.67 3.00 7.49 25.0
L12 Fz20 8.00 4.33 1.63 1.60 0.86, 0.92 23.3
5 8.04 4.33 1.64 1.62 0.86 23.0
A12 5, 12 8.14 4.29 1.38 25.5
A12 5, 12, 19 8.09 4.24 1.31 26.0
D13 Fz20 8.22 4.63 2.73, 2.82 23.3
5 8.23 4.60 2.70, 2.77 24.0
5, 12 8.23 4.59 2.71, 2.76 25.5
5, 12, 19 8.18 4.52 2.62, 2.66 26.0
K14 Fz20 8.15 4.32 1.85, 1.75 1.40, 1.44 1.68 3.00 7.51 eNH3 25.9
5 8.18 4.32 1.76, 1.85 1.37, 1.44 1.68 3.01 7.54 25.3
5, 12 8.17 4.33 1.76, 1.85 1.42 1.68 3.00 7.53 26.0
5, 12, 19 8.12 4.28 1.71, 1.79 1.35 1.61 3.00 7.49 26.0
V15 Fz20 8.03 4.09 2.08 0.93 23.3
5 8.06 4.08 2.06 0.93 26.0
5, 12 8.07 4.08 2.06 0.93 27.5
5, 12, 19 8.02 4.05 2.00 0.90 27.0
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Molecular modeling
One hundred structures were generated for each pep-
tide by simulated annealing calculations involving 16
separate phases using the NMR-derived distance con-
straints and intramolecular hydrogen bond data as de-
scribed previously (Young et al., 1997). For NDVFz20-L5A,
a total of 147 ROEs were assigned from the ROESY
spectrum collected at a mixing time of 300 ms. Of these
ROEs, 70 represented intraresidue interactions, 53 rep-
resented i to i 1 1 interactions, and 27 represented
medium-range (i to i 1 2, i to i 1 3, and i to i 1 4)
interactions. These interactions were converted to inter-
proton distances using the strong, medium, and weak
designations of Clore and Gronenborn (Clore et al., 1985).
This method involves the visual inspection of the ROESY
spectrum and assigning each cross-peak intensity to an
interproton distance of 1.9 to 2.7Å for strong, 1.9 to 3.3Å
for medium, and 1.9 to 4.0Å for weak (see Fig. 3).
As a first step, 20 structures of NDVFz20-L5A were
generated using only interproton distance data to deter-
mine if a secondary structure existed. It was evident from
the resulting structures that a loose helix was present
throughout the peptide. The three intramolecular hydro-
gen bonds determined from the ACSTD study (Table 1)
were assigned based on these structures. Hydrogen
bonds within a reverse turn represent an i to i 1 3
interaction, while those in a helical structure represent
an i to i 1 4 interaction (Creighton, 1984; Wu¨thrich et al.,
1984). Therefore, the three hydrogen bonds were defined
from the amide 1Hs of L12, D13, and T20 to the backbone
carbonyl oxygens of S8, N9, and N16, respectively. All
hydrogen bonds were assigned a distance of 2.5 Å. One
hundred structures were generated for final analysis.
Twenty randomly selected structures of NDVFz20-L5A
are shown in Fig. 4B with backbone atoms superim-
posed from residues 7 through 19. The average energy of
the resulting structures was 250 kcal/mol. The root mean
squared (rms) deviations of the backbone atoms for the
100 structures range from 0.01 to 0.60 Å. For comparison,
the previously calculated structures of NDVFz20 are
shown in Fig. 4A (Young et al., 1997).
For NDVFz20-L5,12A a total of 134 ROEs was assigned
from the ROESY spectrum collected at a mixing time of
300 ms. Of these ROEs, 69 represented intraresidue
interactions, 48 represented i to i 1 1 interactions,
and 19 represented medium-range (i to i 1 2, i to i 1 3,
and i to i 1 4) interactions. One hundred structures
were calculated, and 20 randomly selected structures of
NDVFz20-L5,12A are shown in Fig. 4C with backbone
atoms superimposed in residues 14 through 19. The
average energy of the resulting structures was 240 kcal/
mol. The rms deviations of the backbone atoms for the
100 structures range from 0.01 to 0.40 Å.
For NDVFz20-L5,12,19A a total of 51 ROEs was as-
signed from the ROESY spectrum collected at a mixing
time of 300 ms. Of these ROEs, 36 represented intraresi-
due interactions and 15 represented i to i 1 1 interac-
tions. No medium-range (i to i 1 2, i to i 1 3, and i to i 1
4) interactions were observed in the ROESY spectrum.
One hundred structures were calculated and 20 ran-
domly selected structures of NDVFz20-L5,12,19A are
shown in Fig. 4D with backbone atoms superimposed.
The average energy of the resulting structures was 190
kcal/mol. The rms deviations of the backbone atoms for
the 100 structures range from 5.7 to 2.4 Å.
TABLE 1—Continued
Residue Peptide HN a b g d e ACSTD
N16 Fz20 8.49 4.73 2.72, 2.82 6.88, 7.60 NH2 26.8
5 8.52 4.75 2.73, 2.83 6.90, 7.63 26.9
5, 12 8.53 4.75 2.73, 2.82 6.89, 7.63 27.0
5, 12, 19 8.48 4.70 2.67, 2.76 6.84, 7.59 27.0
V17 Fz20 7.97 4.10 2.08 0.92 210.0
5 8.01 4.10 2.07 0.92 28.3
5, 12 8.03 4.10 2.07 0.92 28.5
5, 12, 19 8.02 4.05 2.00 0.90 27.5
K18 Fz20 8.33 4.36 1.75, 1.84 1.40, 1.44 1.67 2.99 7.51 eNH3 27.2
5 8.36 4.36 1.75, 1.84 1.39, 1.45 1.68 3.00 7.51 26.7
5, 12 8.37 4.36 1.75, 1.84 1.39, 1.46 1.68 2.99 7.53 28.5
5, 12, 19 8.31 4.30 1.69, 1.77 1.37 1.61 3.00 7.49 28.0
L19 Fz20 8.36 4.44 1.66 1.66 0.87, 0.95 29.6
5 8.40 4.44 1.67 1.67 0.87, 0.94 27.0
5, 12 8.40 4.44 1.67 1.67 0.87, 0.94 28.0
A19 5, 12, 19 8.33 4.33 1.35 26.0
T20 Fz20 7.75 4.24 4.29 1.16 23.6
5 7.71 4.20 4.27 1.15 24.0
5, 12 7.71 4.20 4.27 1.16 24.0
5, 12, 19 7.72 4.20 4.11 1.10 26.5
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DISCUSSION
Secondary structures of peptide analogs
The individual backbone dihedral angles were aver-
aged over the 100 structures obtained from molecular
modeling for each peptide analog for comparison to
those of NDVFz20 (Table 2). Dihedral angles that vary by
620° or less are considered sufficient to compare with
ideal dihedral angles of known secondary structural fea-
tures (Creighton, 1984). As previously reported, these
angles for NDVFz20 suggested that this peptide did not
conform to either an ideal a-helix or a 310 helix, but
formed an intermediate structure which allowed the
alignment of the leucines in the zipper position along one
face of the helix (Fig. 4A) (Young et al., 1997). The dihe-
dral angles for NDVFz20-L5A (Table 2) corresponded
very well to those of NDVFz20 from S8 through L19 (see
Fig. 4B). All structures calculated for this peptide formed
a helix with convergence of residues E7 through T19 to
one conformation. There was a large variation in the f
angle for T20 which is expected at the carboxy terminus
due to its increased degree of freedom. In contrast to
NDVFz20, the amino terminus of this peptide from resi-
dues A1 to E7 is much more disordered. While the struc-
tures of the seven amino-terminal residues show con-
siderable variation, each calculated structure is loosely
helical. That is, the amino-terminal third of the peptide
has lost a more rigid rod-like structure, although the
peptide retains an overall helical structure. The structural
studies on the NDVFz20 peptide showed that this pep-
tide was unusually stable due to both side chain salt
bridges and hydrogen bonds (Young et al., 1997). There
FIG. 3. Structural ROEs of NDVFz20 and analogs. ROEs were obtained from the ROESY spectra of NDVFz20, NDVFz20-L5A, NDVFz20-L5,12A, and
NDVFz20-L5,12,19A in aqueous solution at 25°C. The bars show the position and strength of each ROE.
FIG. 4. Structures obtained from molecular modeling. (A) Twenty randomly selected structures of NDVFz20 from simulated annealing calculations using
interproton distance and intramolecular hydrogen bond data (backbone atoms superimposed). A ribbon is shown through the backbone atoms to highlight the
helical structure. Only leucine side chains are shown. (B) Twenty randomly selected structures of NDVFz20-L5A from simulated annealing calculations showing the
loose helical structure at the N-terminus and convergence to a helical structure from residue S8 through T20. Only leucine side chains are shown. (C) Twenty
randomly selected structures of NDVFz20-L5,12A from simulated annealing calculations showing the loss of structure at the N-terminus and convergence to a helical
structure starting at residue K14. Only leucine side chains are shown. (D) Twenty randomly selected structures of NDVFz20-L5,12,19A from simulated annealing
calculations showing random structure.
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were two side chain salt bridges at the N-terminus of
NDVFz20 involving residues K4 to E7 and E7 to K11. Since
only the leucine has been changed in the NDVFz20-L5A
peptide, these side chain salt bridges can still form as
can three hydrogen bonds, perhaps providing sufficient
stabilizing force to retain a flexible helical structure.
In the NDVFz20-L5,12A peptide, both the first and sec-
ond leucines have been replaced with alanine. This
peptide was completely disordered from the amino ter-
minus to residue D13 (Table 2 and Fig. 4C), and there was
no indication of helicity in this region in any of the
structures. Thus, unlike the NDVFz20-L5A peptide, re-
placement of these leucine residues with alanine resi-
dues cannot be overcome by the side chain salt bridges.
However, the presence of the last leucine in the zipper
position as well as the remaining hydrogen bond involv-
ing residue T20 does apparently provide stabilization of
the carboxy terminus, since there was considerable
structure in this region of the molecule. All structures
converge in this region to an a helix instead of the
intermediate helix found in the NDVFz20 peptide.
In the NDVFz20-L5,12,19A peptide, all leucines have
been replaced with alanines, which resulted in a com-
plete loss of structure (Fig. 4D) throughout the peptide. In
fact the chemical shifts and ROE connectivities obtained
from 2D NMR data are characteristic of a peptide with
random conformation in solution. This loss of structure
argues strongly that the leucine residues play a major
role in the rigid helical structure of the leucine containing
peptide. Furthermore, the progressive loss of structure
TABLE 2
Backbone Dihedral Angles of the 100 Structures Calculated from Molecular Modeling
for NDVFz20, NDVFz20-L5A, NDVFz20-L5,12A, and NDVFz20-L5,12,19A
NDVFz20 L5A L5,12A L5,12,19A
A1 f 5 — — — —
c 5 251.1 6 28.0 31.0 6 103.2 272.6 6 122.2 44.9 6 104.6
L2 f 5 263.4 6 9.6 254.3 6 45.9 288.3 6 7.1 257.9 6 64.3
c 5 230.4 6 3.0 242.7 6 8.6 270.0 6 5.0 71.4 6 79.4
D3 f 5 281.3 6 1.1 275.8 6 3.6 283.6 6 105.1 296.6 6 24.2
c 5 226.9 6 2.3 73.8 6 80.6 113.3 6 95.1 43.6 6 107.3
K4 f 5 267.6 6 5.2 217.0 6 67.5 282.3 6 51.8 274.0 6 50.1
c 5 238.5 6 4.8 42.9 6 2.2 121.7 6 40.7 43.3 6 102.3
L5 f 5 263.3 6 1.8 A5 261.9 6 2.1 A5 279.7 6 5.7 A5 279.6 6 80.0
c 5 230.5 6 2.0 216.5 6 6.5 17.1 6 137.8 41.2 6 99.6
E6 f 5 263.1 6 6.1 2104.0 6 18.4 285.0 6 7.4 2103.4 6 28.4
c 5 228.2 6 5.9 22.9 6 25.5 105.1 6 57.8 57.2 6 94.5
E7 f 5 270.1 6 4.9 2125.6 6 19.0 2101.9 6 12.8 291.4 6 18.9
c 5 242.2 6 2.5 270.0 6 7.1 279.4 6 43.3 56.0 6 87.1
S8 f 5 253.6 6 1.0 257.9 6 3.0 271.6 6 16.9 244.8 6 90.3
c 5 229.5 6 1.4 228.1 6 4.8 231.2 6 31.5 26.0 6 104.5
N9 f 5 268.3 6 1.1 2126.3 6 9.0 234.0 6 76.3 284.3 6 10.2
c 5 229.5 6 8.6 228.1 6 3.6 226.7 6 70.6 64.6 6 85.6
S10 f 5 264.6 6 9.2 275.1 6 1.8 283.3 6 10.9 275.6 6 57.8
c 5 228.6 6 10.9 231.6 6 4.0 28.7 6 87.7 30.1 6 117.1
K11 f 5 269.3 6 2.6 253.4 6 6.4 227.1 6 58.6 2103.5 6 70.0
c 5 236.4 6 9.4 236.1 6 5.3 242.9 6 59.4 65.8 6 97.6
L12 f 5 262.3 6 2.3 264.8 6 3.1 A12 287.9 6 71.1 A12 291.6 6 26.2
c 5 226.9 6 9.6 237.5 6 3.9 288.8 6 30.3 26.1 6 118.6
D13 f 5 273.8 6 6.4 261.4 6 1.7 1.74 6 75.1 244.6 6 78.4
c 5 232.1 6 5.9 235.9 6 6.2 32.7 6 39.0 35.2 6 96.4
K14 f 5 291.1 6 7.0 276.1 6 3.4 2123.5 6 81.4 257.7 6 87.7
c 5 225.9 6 6.9 232.8 6 2.7 257.1 6 3.9 72.1 6 77.5
V15 f 5 276.6 6 4.0 282.2 6 8.9 261.9 6 6.2 284.8 6 7.5
c 5 240.1 6 4.5 248.9 6 2.4 241.1 6 8.8 74.7 6 109.1
N16 f 5 266.5 6 4.3 277.1 6 2.2 270.3 6 3.7 254.0 6 83.6
c 5 224.7 6 9.9 233.4 6 2.2 230.1 6 2.2 92.9 6 65.3
V17 f 5 280.1 6 7.0 287.7 6 3.8 271.5 6 2.4 218.0 6 83.8
c 5 225.4 6 9.0 232.2 6 4.2 229.9 6 3.9 213.3 6 91.2
K18 f 5 256.8 6 6.1 269.7 6 2.3 257.1 6 4.6 231.5 6 89.7
c 5 225.7 6 8.2 235.6 6 2.3 236.5 6 4.0 103.9 6 69.8
L19 f 5 264.1 6 8.7 261.8 6 1.2 261.4 6 2.1 A19 259.4 6 70.9
c 5 246.4 6 7.9 245.7 6 4.8 240.9 6 2.5 63.6 6 90.6
T20 f 5 232.9 6 81.9 267.8 6 99.8 241.7 6 87.9 295.8 6 62.2
c 5 — — — —
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from amino terminus to carboxy terminus as the leucines
are replaced with alanines also argues for the impor-
tance of these residues in the solution conformation of
the peptide.
Activities of peptide analogs
Leucine zipper motifs, extending three to five heptad
repeats, are a recognized characteristic of the fusion
proteins of paramyxoviruses, retroviruses, and coronavi-
ruses (Chambers et al., 1990; deGroot et al., 1987). The
importance of these sequences in the fusion activity of
these viral fusion proteins has been suggested by mu-
tational analysis of the region of the intact protein and as
well as studies of peptide inhibitors with sequences from
these regions.
Mutational analyses of the leucine zipper motif of the
HIV gp41 have focused on single amino acid changes.
Dubay et al. (1992) showed that conservative changes of
a central isoleucine residue had minimal effects on fu-
sion, but nonconservative changes eliminated fusion.
Interestingly, introduction of a single proline residue in
the zipper motif as well as other regions of the predicted
helix also eliminated fusion activity, implying the impor-
tance of the secondary structure of the region (Chen,
1994; Wild et al., 1994). Similarly, mutations in this region
of the coronavirus envelope protein can eliminate fusion
activity (Gallagher et al., 1991). Mutational studies of the
paramyxovirus F protein, reported in two systems (Buck-
land et al., 1992; Reitter et al., 1995), showed that replace-
ment of individual leucine residues had little effect, but
replacement of at least two residues eliminated the ac-
tivity of the protein.
In an alternative approach, Wild et al. (1992) first re-
ported that a synthetic peptide with the sequence of this
region of gp41 inhibited fusion directed by HIV env pro-
teins. Similarly, leucine zipper peptides from F proteins of
measles virus, Sendai virus, parainfluenza 2, parainflu-
enza 3, and NDV inhibit fusion directed by proteins from
the homologous viruses (Lambert et al., 1996; Rapaport
et al., 1995; Wild and Buckland, 1997; Yao and Compans,
1996). The mechanisms involved in inhibition of fusion
are unknown; however, it has been proposed that the
inhibitory activities of these peptides are due to their
ability to mimic functional domains of the corresponding
fusion protein, thereby interfering with the normal func-
tion of the protein (Lambert et al., 1996; Rapaport et al.,
1995; Wild and Buckland, 1997; Yao and Compans, 1996).
Thus analysis of the effects of substitutions in the pep-
tide sequence on the structure and function of peptide
inhibitors may provide insights into the role of the leucine
zipper motif in the intact protein as well as the effect of
mutations in the intact protein.
There is one report of structural and functional analy-
sis of peptide analogs of the HIV peptide inhibitor. Re-
placement of a central isoleucine residue in the zipper
motif with proline or serine destablized the helical struc-
ture of the peptide, as determined by circular dichroism,
and eliminated activity of the peptide (Wild et al., 1994).
Replacement of this residue with alanine resulted in a
less stable helical structure with reduced inhibitory ac-
tivity. Such results argue that the isoleucine residue in
the motif is important for the structural integrity of the
peptide and that it is this structure that is important for
the inhibitory activity.
Similarly, results reported here show that replacement
of leucine residues with alanine destabilized the struc-
ture of NDVFz20 peptide, with a concomitant loss of
activity. Replacement of a single leucine in the zipper
motif of NDVFz20 with alanine resulted in some loss of
inhibitory activity, while replacement of two of these
residues further impaired activity. Replacement of all
leucine residues with alanines virtually eliminated activ-
ity of the peptide. This progressive loss in inhibitory
activity correlated with a progressive loss in ordered
secondary structure. These results argue that the or-
dered helical structure of the peptide is important for
inhibitory activity. Furthermore, effects of changes in the
peptide sequence correlate well with results of muta-
tional studies of intact proteins where the most signifi-
cant effects occur in mutants with more than one leucine
residue changed. The results further suggest that alter-
ations of leucine residues in the zipper motif in the intact
protein disrupt local secondary structure in a region of
the protein important for fusion activity of the protein.
That the replacement of leucine residues with alanine
should have such a profound effect on the ordered struc-
ture of the peptide was surprising and is the subject of
further investigation.
MATERIALS AND METHODS
Peptides
The peptides NDVFz20-L5A, NDVFz20-L5,12A, and
NDVFz20-L5,12,19A, peptide analogs of a 20-amino-acid
segment (aa 478–497) of HR2 of the NDV F protein, were
obtained from Tufts University School of Medicine Pep-
tide Core Facility (136 Harrison Avenue, Boston, MA). The
peptides were purified by the Tufts facility to 98% using
HPLC and used for both biological and NMR studies
without further purification.
The peptide nomenclature indicates the paramxyovi-
rus protein from which the sequence was derived (for
example NDV F), motif location (z for zipper), and length
in numbers of amino acids. Peptides with sequences
altered from the wild-type sequence are further indicated
by the original residue, the position in the peptide of the
alteration, and the substituted residue. Using this no-
menclature, the ‘‘wild-type’’ peptide previously described
(WTF20) (Young et al., 1997) is here designated NDVFz20.
29STABILITY OF A PEPTIDE INHIBITOR OF VIRUS FUSION
Cells and plasmids
Cos-7 cells, obtained from the American Type Culture
Collection, were maintained in Dulbecco’s modified Ea-
gle’s medium (DMEM) supplemented with nonessential
amino acids, vitamins, penicillin/streptomycin, and 10%
fetal calf serum. NDV HN and F genes (derived from
strain AV, a strain which contains an F protein which is
cleaved intracellularly (Glickman et al., 1988; Toyoda et
al., 1987)) were expressed in Cos cells using pSVL ob-
tained from Pharmacia as previously described (Sergel
et al., 1993).
Transfections
Cos cells were plated at 2 3 105 per 35-mm plate and
transfected 18 h later. For each 35-mm plate, a mix of 1.5
mg HN DNA and 1.5 mg F DNA in 0.1 ml OptiMem and 10
ml of Lipofectin (BRL/GIBCO) in 0.1 ml of OptiMem was
incubated at room temperature for 45 min and then
diluted with 0.7 ml OptiMem and added to a plate previ-
ously washed with OptiMem. Cells were incubated with
the Lipofectin-DNA for 5.5 h and then 2 ml of Cos cell
medium was added.
Fusion assays
At 48 h posttransfection, the number of nuclei in 40
fusion areas was counted to determine the average size
at each time point as previously described (Sergel et al.,
1993). Values obtained after transfection of the vector
alone were subtracted.
NMR sample preparation and experiments
NMR samples were prepared by dissolving 2 mg of the
synthetic peptide in 500 ml of 90% 1H2O/10%
2H2O to a
final concentration of 1.60 mM (90% purity correction).
The solution was buffered to pH 4.00 using 30 mM
deuterated sodium acetate. Sodium 2,2-dimethyl-2-sila-
pentane-5-sulfonate (DSS) was used as an internal
chemical shift reference.
All NMR experiments were conducted at the Missis-
sippi State Magnetic Resonance Facility in the Chemistry
Department of Mississippi State University on a Bruker
AMX-600 MHz NMR spectrometer with the use of the 1H
channel of a triple resonance probe (1H/13C/15N). Spectra
were processed and interpreted at the University of Mas-
sachusetts Medical Center using Felix 95.0 from Molec-
ular Simulations Inc. on a Silicon Graphics Impact10000:
Indigo2.
The 1D 1H spectra were acquired every 5°C over a
temperature range of 20 to 45°C at a spectral width of
7812.5 Hz, with 32K data points for a digital resolution of
0.2211 Hz per point, yielding a total acquisition time of
2.261 s. A total of 32 scans was acquired and then
processed to 64K points with an exponential multiplica-
tion of 1 Hz line broadening. The 1H2O signal was sup-
pressed using watergate with a sine gradient.
Six phase-sensitive watergate-TOCSY (Eich et al.,
1982; Hicks and Young, 1994) experiments were acquired
every 5°C over a temperature range of 20 to 45°C using
a spin-lock mixing pulse of 80 ms and a MLEV-17 mixing
sequence with a 2.5-ms trim pulse at the beginning and
the end of the MLEV sequence (Bax and Davis, 1985).
The spectral width in both domains was set to 7812.5 Hz,
yielding a digital resolution of 15.26 Hz per point in f1 and
3.81 Hz per point in f2 and a total acquisition time of
0.1311 s. At the beginning of each experiment, 32 dummy
scans were collected to allow the system to reach ther-
mal equilibrium. A total of 2K time-domain data points for
512 t1 values of 32 scans each was acquired and then
zero filled to 4K 3 4K, followed by processing with a 90°
shifted sine function in both dimensions. After investiga-
tion of each TOCSY spectrum, it was determined that the
experiment acquired at 25°C provided the best amide
peak-to-peak resolution.
The phase-sensitive watergate-ROESY (Bull, 1988) ex-
periment was acquired with a mixing pulse of 300 ms at
25°C. The spectral width in both domains was set to
7812.5 Hz, yielding a digital resolution of 7.62 Hz per point
in f1 and 3.81 Hz per point in f2 and a total acquisition
time of 0.1311 s. At the beginning of each experiment, 32
dummy scans were collected to allow the system to
reach thermal equilibrium. A total of 2K time-domain data
points for 512 t1 values of 64 scans each was acquired
and then zero filled to 4K 3 4K, followed by processing
with a 90° shifted sine function in both dimensions.
Molecular modeling
The molecular modeling (simulated annealing) calcu-
lations were performed using the BioSym software (In-
sightII, NMRchitect, and Discover) from Molecular Sim-
ulations Inc. on a Silicon Graphics Impact10000: Indigo2
at the University of Massachusetts Medical Center.
Structures were generated from NMR-derived interpro-
ton distance restraints and hydrogen bond data using
simulated annealing protocols as previously described
(Young et al., 1997).
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